Peptide tyrosine tyrosine (PYY) as a new strategy for treating obesity
Background Obesity is a risk factor for obesity-related disorders such as type 2 diabetes mellitus, vascular disease, osteoarthritis, sleep apnea, and malignancy. Obesity cohinder the individual work capacity, and the cost for managing obesity complications is high. Objective The objective of this r...
Main Author: | Ahmed Mostafa Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Al-Azhar Assiut Medical Journal |
Subjects: | |
Online Access: | http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2016;volume=14;issue=3;spage=101;epage=108;aulast=Mahmoud |
Similar Items
-
A Cross-Sectional Comparative Study: Could Asprosin and Peptide Tyrosine-Tyrosine Be Used in Schizophrenia to Define the Disease and Determine Its Phases?
by: Elif Özcan Tozoğlu, et al.
Published: (2025-03-01) -
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
Published: (2012-01-01) -
GLP-1 and PYY for the treatment of obesity: a pilot study on the use of agonists and antagonists in diet-induced rats
by: Marie Oertel, et al.
Published: (2024-02-01) -
Involvement of protein tyrosine phosphatases in adipogenesis: New anti-obesity targets?
by: Kwang-Hee Bae
Published: (2012-12-01) -
Orientation of tyrosine side chain in neurotoxic Aβ differs in two different secondary structures of the peptide
by: Swagata Das, et al.
Published: (2016-01-01)